Of note, we recently and firstly showed a high and significant correlation between NOS2 and SOX-2 expression in glioma cells [28].Collectively, all of these studies, among others, suggest that NO signaling plays an important role in GSC maintenance and resistance to anticancer therapies. The gene discussed is SOX2; the disease is central nervous system cancer.